- Home
- ONEG vs BDTX Comparison
ONEG vs BDTX Comparison
Compare ONEG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- BDTX
- Stock Information
- Founded
- ONEG 2021
- BDTX 2014
- Country
- ONEG Hong Kong
- BDTX United States
- Employees
- ONEG 26
- BDTX N/A
- Industry
- ONEG Homebuilding
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONEG Consumer Discretionary
- BDTX Health Care
- Exchange
- ONEG Nasdaq
- BDTX Nasdaq
- Market Cap
- ONEG 181.8M
- BDTX 181.4M
- IPO Year
- ONEG 2024
- BDTX 2020
- Fundamental
- Price
- ONEG $11.42
- BDTX $3.71
- Analyst Decision
- ONEG
- BDTX Strong Buy
- Analyst Count
- ONEG 0
- BDTX 6
- Target Price
- ONEG N/A
- BDTX $12.50
- AVG Volume (30 Days)
- ONEG 260.4K
- BDTX 968.2K
- Earning Date
- ONEG 01-01-0001
- BDTX 11-04-2025
- Dividend Yield
- ONEG N/A
- BDTX N/A
- EPS Growth
- ONEG N/A
- BDTX N/A
- EPS
- ONEG 0.08
- BDTX 0.25
- Revenue
- ONEG $53,205,000.00
- BDTX $70,000,000.00
- Revenue This Year
- ONEG N/A
- BDTX N/A
- Revenue Next Year
- ONEG N/A
- BDTX N/A
- P/E Ratio
- ONEG $147.84
- BDTX $13.58
- Revenue Growth
- ONEG N/A
- BDTX N/A
- 52 Week Low
- ONEG $1.48
- BDTX $1.20
- 52 Week High
- ONEG $13.50
- BDTX $4.50
- Technical
- Relative Strength Index (RSI)
- ONEG 52.74
- BDTX 66.55
- Support Level
- ONEG $10.08
- BDTX $3.01
- Resistance Level
- ONEG $11.82
- BDTX $3.43
- Average True Range (ATR)
- ONEG 0.86
- BDTX 0.20
- MACD
- ONEG -0.31
- BDTX 0.02
- Stochastic Oscillator
- ONEG 42.25
- BDTX 94.59
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.